Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tenon Medical (TNON) Cash from Financing Activities (2021 - 2025)

Tenon Medical (TNON) has 5 years of Cash from Financing Activities data on record, last reported at $59000.0 in Q3 2025.

  • For Q3 2025, Cash from Financing Activities fell 99.39% year-over-year to $59000.0; the TTM value through Sep 2025 reached $6.4 million, down 58.58%, while the annual FY2024 figure was $14.1 million, 124.14% up from the prior year.
  • Cash from Financing Activities reached $59000.0 in Q3 2025 per TNON's latest filing, up from -$59000.0 in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at $14.2 million in Q2 2022 and bottomed at -$179000.0 in Q4 2021.
  • Average Cash from Financing Activities over 5 years is $3.1 million, with a median of $266000.0 recorded in 2023.
  • Peak YoY movement for Cash from Financing Activities: skyrocketed 10507.14% in 2024, then tumbled 99.39% in 2025.
  • A 5-year view of Cash from Financing Activities shows it stood at -$179000.0 in 2021, then soared by 86.03% to -$25000.0 in 2022, then skyrocketed by 5584.0% to $1.4 million in 2023, then plummeted by 91.76% to $113000.0 in 2024, then tumbled by 47.79% to $59000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Cash from Financing Activities were $59000.0 in Q3 2025, -$59000.0 in Q2 2025, and $6.3 million in Q1 2025.